Thermo Fisher Scientific Inc. (NEO: TMO)
Canada
· Delayed Price · Currency is CAD 19.54
+0.33 (1.72%)
Dec 20, 2024, 3:23 PM EST
Thermo Fisher Scientific Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 28, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 42,370 | 42,857 | 44,915 | 39,211 | 32,218 | 25,542 | Upgrade
|
| Revenue Growth (YoY) | -2.42% | -4.58% | 14.55% | 21.71% | 26.14% | 4.86% | Upgrade
|
| Cost of Revenue | 25,132 | 25,744 | 25,944 | 19,573 | 16,214 | 14,214 | Upgrade
|
| Gross Profit | 17,238 | 17,113 | 18,971 | 19,638 | 16,004 | 11,328 | Upgrade
|
| Selling, General & Admin | 8,512 | 8,381 | 8,940 | 7,857 | 6,940 | 6,139 | Upgrade
|
| Research & Development | 1,343 | 1,337 | 1,471 | 1,406 | 1,181 | 1,003 | Upgrade
|
| Other Operating Expenses | 1 | 1 | - | 3 | 16 | - | Upgrade
|
| Operating Expenses | 9,856 | 9,719 | 10,411 | 9,266 | 8,137 | 7,142 | Upgrade
|
| Operating Income | 7,382 | 7,394 | 8,560 | 10,372 | 7,867 | 4,186 | Upgrade
|
| Interest Expense | -1,463 | -1,375 | -726 | -536 | -553 | -676 | Upgrade
|
| Interest & Investment Income | 1,160 | 879 | 272 | 43 | 65 | 224 | Upgrade
|
| Earnings From Equity Investments | -76 | -59 | -172 | -4 | -3 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -16 | -29 | 102 | 162 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -19 | 5 | -35 | -161 | 5 | 65 | Upgrade
|
| EBT Excluding Unusual Items | 6,968 | 6,815 | 8,001 | 9,876 | 7,381 | 3,799 | Upgrade
|
| Merger & Restructuring Charges | -5 | -233 | -68 | -72 | -132 | -52 | Upgrade
|
| Gain (Loss) on Sale of Investments | -6 | -46 | -161 | 66 | 10 | 44 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 14 | - | - | 482 | Upgrade
|
| Asset Writedown | -219 | -219 | -60 | -122 | -32 | - | Upgrade
|
| Legal Settlements | -19 | -19 | - | - | - | - | Upgrade
|
| Other Unusual Items | 41 | -59 | -63 | -911 | - | -201 | Upgrade
|
| Pretax Income | 6,760 | 6,239 | 7,663 | 8,837 | 7,227 | 4,072 | Upgrade
|
| Income Tax Expense | 640 | 284 | 703 | 1,109 | 850 | 374 | Upgrade
|
| Earnings From Continuing Operations | 6,120 | 5,955 | 6,960 | 7,728 | 6,377 | 3,698 | Upgrade
|
| Net Income to Company | 6,120 | 5,955 | 6,960 | 7,728 | 6,377 | 3,698 | Upgrade
|
| Minority Interest in Earnings | 15 | 40 | -10 | -3 | -2 | -2 | Upgrade
|
| Net Income | 6,135 | 5,995 | 6,950 | 7,725 | 6,375 | 3,696 | Upgrade
|
| Net Income to Common | 6,135 | 5,995 | 6,950 | 7,725 | 6,375 | 3,696 | Upgrade
|
| Net Income Growth | 3.27% | -13.74% | -10.03% | 21.18% | 72.48% | 25.80% | Upgrade
|
| Shares Outstanding (Basic) | 383 | 386 | 392 | 394 | 396 | 400 | Upgrade
|
| Shares Outstanding (Diluted) | 384 | 388 | 394 | 397 | 399 | 403 | Upgrade
|
| Shares Change (YoY) | -1.16% | -1.52% | -0.76% | -0.50% | -0.99% | -0.74% | Upgrade
|
| EPS (Basic) | 16.02 | 15.53 | 17.73 | 19.61 | 16.10 | 9.24 | Upgrade
|
| EPS (Diluted) | 15.95 | 15.45 | 17.63 | 19.46 | 15.96 | 9.17 | Upgrade
|
| EPS Growth | 4.56% | -12.37% | -9.40% | 21.93% | 74.05% | 26.66% | Upgrade
|
| Free Cash Flow | 7,775 | 6,927 | 6,911 | 6,789 | 6,815 | 4,047 | Upgrade
|
| Free Cash Flow Per Share | 20.23 | 17.85 | 17.54 | 17.10 | 17.08 | 10.04 | Upgrade
|
| Dividend Per Share | 1.520 | 1.400 | 1.200 | 1.040 | 0.880 | 0.760 | Upgrade
|
| Dividend Growth | 12.59% | 16.67% | 15.38% | 18.18% | 15.79% | 11.76% | Upgrade
|
| Gross Margin | 40.68% | 39.93% | 42.24% | 50.08% | 49.67% | 44.35% | Upgrade
|
| Operating Margin | 17.42% | 17.25% | 19.06% | 26.45% | 24.42% | 16.39% | Upgrade
|
| Profit Margin | 14.48% | 13.99% | 15.47% | 19.70% | 19.79% | 14.47% | Upgrade
|
| Free Cash Flow Margin | 18.35% | 16.16% | 15.39% | 17.31% | 21.15% | 15.84% | Upgrade
|
| EBITDA | 10,582 | 10,800 | 11,941 | 12,964 | 10,192 | 6,463 | Upgrade
|
| EBITDA Margin | 24.98% | 25.20% | 26.59% | 33.06% | 31.63% | 25.30% | Upgrade
|
| D&A For EBITDA | 3,200 | 3,406 | 3,381 | 2,592 | 2,325 | 2,277 | Upgrade
|
| EBIT | 7,382 | 7,394 | 8,560 | 10,372 | 7,867 | 4,186 | Upgrade
|
| EBIT Margin | 17.42% | 17.25% | 19.06% | 26.45% | 24.42% | 16.39% | Upgrade
|
| Effective Tax Rate | 9.47% | 4.55% | 9.17% | 12.55% | 11.76% | 9.18% | Upgrade
|
| Revenue as Reported | 42,370 | 42,857 | 44,915 | 39,211 | 32,218 | 25,542 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.